Cardio Diagnostics Holdings is trading at $2.07, +5.61% in after-hours trading with no clear company-specific catalyst identified.

  • The move came during a broader risk-off session, with major U.S. indices declining.
  • No major company-specific announcement dated September 8, 2026 was identified; available coverage reports no significant recent news.
  • Earlier Iowa laboratory and rural-care announcements remain potential background interest, while the gain appears speculative or liquidity-driven rather than tied to confirmed earnings or breaking news.